focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,360.00
Bid: 12,328.00
Ask: 12,332.00
Change: -4.00 (-0.03%)
Spread: 4.00 (0.032%)
Open: 12,358.00
High: 12,376.00
Low: 12,256.00
Prev. Close: 12,364.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll

Wed, 04th Nov 2020 17:06

(Alliance News) - Stocks in London surged to a strong finish Wednesday as a tight US presidential election started to open up for Democratic challenger Joe Biden.

The FTSE 100 index got off to a sluggish start, but was able to close the session up 96.49 points, or 1.7% at 5,883.26 Wednesday. The blue-chip index had fallen by 1.0% to a low of 5,731.07 during a frenetic open.

The mid-cap FTSE 250 added 304.38 points, or 1.7%, at 17,796.08. The AIM All-Share closed up 15.36 points, 1.6%, at 974.74.

The Cboe UK 100 index closed up 1.7% at 584.13. The Cboe 250 ended up 1.5% at 14,961.24. The Cboe Small Companies grew 1.3% at 9,623.16.

The CAC 40 stock index in Paris advanced 2.4%, and Frankfurt's DAX 30 climbed 2.0%.

"It appears that once again investors are buying into a Joe Biden presidency, despite the race - which could still have days left in it yet - being on a knife-edge," SpreadEx analyst Connor Campbell said.

He continued: "Investors seem to be taking a kind of win-win attitude to the election. Yesterday's growth was based on the hopes of a blue wave led stimulus package. Now that the race is much tighter, and the Democrats have little chance of taking the Senate, the markets are celebrating the likelihood of preserved tax cuts and no healthcare reform."

President Donald Trump prematurely declared victory and sought Supreme Court intervention to stop vote-counting - even as his Democratic rival Joe Biden voiced confidence in his own chances.

Shattering norms in the world's most powerful democracy, Trump alleged "major fraud" as he held an upbeat rally inside the White House's ceremonial East Room.

Attention was again turning to three northern states that elected Trump four years ago - Michigan, Pennsylvania and Wisconsin - with early ballots still waiting to be counted from the Democratic stronghold cities of Detroit, Philadelphia and Milwaukee.

Pennsylvania Governor Tom Wolf said the state may not know its full election results on Wednesday. Wolf, a Democrat, urged patience, and said Pennsylvania intends to keep "the promise of democracy" that every vote counts.

Stocks in New York were in firmly green at the London equities close, with the Dow Jones Industrial Average up 2.4%, the S&P 500 index up 3.0%, and the Nasdaq Composite up 4.0%.

Oanda's Edward Moya said: "The Senate will likely stay red (that could change, but it is leaning heavily that way) and the Democrats House majority lead will shrink which means we won't see tax hikes, tougher regulation, and massive stimulus spending. The Nasdaq will outperform, and the great cyclical rotation won't happen anytime soon. Regardless of what happens with the presidential race over the next few days, financial markets are pricing a much more accommodative Fed and that should be bullish for US stocks."

In London, pharma firms were enjoying the potential split vote in the US, avoiding any regulations a Democratic-dominated Washington may have imposed.

AstraZeneca gained 6.6%, Hikma 2.5% and GlaxoSmithKline 4.4%.

IG senior market analyst Joshua Mahony added: "Astrazeneca has enjoyed a welcome boost in the wake of the news that the UK government could end up rolling out their vaccine as early as December. With Pfizer and Astrazeneca trials leading the way, much has been staked on the ability to find a suitable vaccine of from one of those two trials.

"For the short-term everyone has been caught up in election and lockdown fears, yet the ability to bring a vaccine to market out of these two front-runners will be critical in ensuring that we begin to see the end of this crisis."

Marks & Spencer added 5.1%. The retailer's interim performance was better than expected, despite swinging to a pretax loss of GBP87.6 million from a GBP158.8 million profit.

Revenue for the six months to September declined 16% to GBP4.09 billion from GBP4.86 billion a year before.

"Despite the company's historic loss, there are some encouraging signs in Marks & Spencer's update. The initial success of the Ocado partnership is highly promising and appears to be unlocking the food business's previously untapped online potential," said Brewin Dolphin Senior Investment Manager John Moore.

Ocado shares closed 5.3% higher.

Smurfit Kappa added 3.9%. The paper firm said its third-quarter performance was ahead of its expectations, with revenue year-to-date not far behind the prior year.

Dublin-based Smurfit reported revenue of EUR6.61 billion for the nine months ended September 30, down 3.5% from EUR6.85 billion the year before.

Smurfit also reported earnings before interest, tax, depreciation and amortisation of EUR1.13 billion, a 10% drop from EUR1.26 billion for the same period of 2019 but flat versus 2018's Ebitda figure.

Amid the chaos of the US election, blue-chip banks were bearing the brunt of the move into more defensive stocks, which is in stark contrast to the gains financials made on Tuesday prior to the polls closing in the US.

Standard Chartered lost 4.7% Wednesday, HSBC 4.2%, Barclays 2.6%, Lloyds 2.5% and NatWest 2.2%.

Defensive stocks, in contrast, fared bettered. Diageo added 3.6%, British American Tobacco 3.5% and BAE Systems 2.8%.

Turning to forex, the dollar had a strong start to the European session on Wednesday though its gains waned throughout the day.

The pound was quoted at USD1.2977 on Wednesday evening, down from USD1.3070 at the London equities close on Tuesday. However, sterling was as low as USD1.2915 earlier in trading.

The euro slipped to USD1.1710, from USD1.1729 late Tuesday.

Versus the yen, the dollar fetched JPY104.49, broadly flat from JPY104.50 at the London market close on Tuesday.

A barrel of the North Sea benchmark fetched USD40.62 Wednesday, up from USD39.64 a barrel at the London market close Tuesday.

Gold was quoted at USD1,901.50, down from USD1,906.10.

It's a big day in the international economic calendar Thursday, with interest rate decisions due from the Bank of England, at 0700 GMT, and the US Federal Reserve, at 1900 GMT.

Bank of America expects rising Covid-19 cases and restrictions, both in the UK and abroad, to cut the BoE's growth forecast for the UK economy by 40 basis points for 2020 and 140 basis points for 2021. The BoE now will likely model a GDP slide of 9.9% in 2020 and a rebound of 7.7% in 2021.

"In short we expect the BoE to continue moving from a 'V' to 'U'. Weaker growth should mean lower inflation at the policy relevant two-year horizon," Bank of America said, referring to the shape graph charting economic recovery.

Analysts are near unanimous in expecting the BoE to top up QE by a further GBP100 billion on Thursday in response to the darkening backdrop, after bumping up the programme by GBP100 billion in June to take the total stock of asset purchases to GBP745 billion.

Though it is all but certain the BoE will ease monetary policy this week, analysts don't think the bank will go as far as cutting interest rates into negative territory.

Elsewhere, there is a Jibun Bank services PMI print overnight, with Germany factory orders at 0600 GMT, and UK Markit construction PMI at 0930 GMT. Eurozone retail sales are due at 1000 GMT and the weekly US initial jobless claims are out at 1330 GMT.

In the UK corporate calendar, pharma giant AstraZeneca will issue third quarter results, blue chip grocer Sainsbury's, budget airline Wizz Air and Auto Trader will publish half-year results. Insurers RSA and Lancashire will release third quarter results.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.